Candidate canine enterogastrones: Acid inhibition before and after vagotomy

Kevin C K Lloyd, S. Amirmoazzami, F. Friedik, A. Heynio, T. E. Solomon, J. H. Walsh

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The relative contributions of several gut-derived peptides as enterogastrones known to be released in response to a fatty meal and to inhibit acid secretion have not previously been compared directly. We determined the acid-inhibitory activities of increasing intravenous doses of several peptides before and after highly selective vagotomy (HSV) during intragastric titration of a peptone meal in dogs. Before HSV, threshold inhibitory doses of peptide YY (PYY), cholecystokinin (CCK), and secretin were 5, 7, and 10 pmol · kg-1 · h-1, respectively, whereas neurotensin, glucagon-like peptide-1 (GLP-1), and oxyntomodulin failed to inhibit acid secretion at doses up to 1,000 pmol · kg-1 · h-1. The calculated dose producing 50% acid inhibition (ID50) of secretin (62 pmol · kg-1 · h- 1) was one-half that of PYY (128 pmol · kg-1 · h-1). Maximal (90%) acid inhibition was produced by 100 pmol · kg-1 · h-1 secretin and 500 pmol · kg-1 PYY. The highest dose of CCK that did not cause vomiting (100 pmol · kg-1 · h-1) inhibited peptone-stimulated acid output by only 60%. After HSV, 500 pmol · kg-1 · h-1 pyy and 200 pmol · kg-1 · h- 1 failed to inhibit acid output by more than 50%. Threshold doses for inhibition by PYY and CCK were 200 and 100 pmol · kg-1 · h-1, respectively. Secretin remained a potent inhibitor after HSV, with an ID50 of 80 pmol · kg-1 · h-1 and a threshold dose of 10 pmol · kg-1 · h-1. HSV also failed to affect inhibition caused by somatostatin. This study has shown that PYY and secretin are somewhat more potent and efficacious inhibitors of acid secretion than CCK but that all three peptides are far more active than GLP-1, neurotensin, and oxyntomodulin. PYY and CCK inhibit acid secretion in large part through vagal innervation of the gastric fundus, but the inhibitory effects of secretin are independent of fundic vagal innervation.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Gastrointestinal and Liver Physiology
Volume272
Issue number5 35-5
StatePublished - May 1997

Fingerprint

Vagotomy
Peptide YY
Canidae
Secretin
Proximal Gastric Vagotomy
Cholecystokinin
Acids
Oxyntomodulin
Neurotensin
Peptones
Glucagon-Like Peptide 1
Peptides
Meals
Gastric Fundus
enterogastrone
Somatostatin
Vomiting
Dogs

Keywords

  • Cholecystokinin
  • Gastric acid secretion
  • Gastric inhibitory peptide
  • Glucagon-like peptide- 1
  • Neurotensin
  • Oxyntomodulin
  • Peptide YY
  • Secretin
  • Somatostatin

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology
  • Physiology (medical)

Cite this

Candidate canine enterogastrones : Acid inhibition before and after vagotomy. / Lloyd, Kevin C K; Amirmoazzami, S.; Friedik, F.; Heynio, A.; Solomon, T. E.; Walsh, J. H.

In: American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 272, No. 5 35-5, 05.1997.

Research output: Contribution to journalArticle

Lloyd, Kevin C K ; Amirmoazzami, S. ; Friedik, F. ; Heynio, A. ; Solomon, T. E. ; Walsh, J. H. / Candidate canine enterogastrones : Acid inhibition before and after vagotomy. In: American Journal of Physiology - Gastrointestinal and Liver Physiology. 1997 ; Vol. 272, No. 5 35-5.
@article{8abb23274f604b1aa13a7e5dc2b8465b,
title = "Candidate canine enterogastrones: Acid inhibition before and after vagotomy",
abstract = "The relative contributions of several gut-derived peptides as enterogastrones known to be released in response to a fatty meal and to inhibit acid secretion have not previously been compared directly. We determined the acid-inhibitory activities of increasing intravenous doses of several peptides before and after highly selective vagotomy (HSV) during intragastric titration of a peptone meal in dogs. Before HSV, threshold inhibitory doses of peptide YY (PYY), cholecystokinin (CCK), and secretin were 5, 7, and 10 pmol · kg-1 · h-1, respectively, whereas neurotensin, glucagon-like peptide-1 (GLP-1), and oxyntomodulin failed to inhibit acid secretion at doses up to 1,000 pmol · kg-1 · h-1. The calculated dose producing 50{\%} acid inhibition (ID50) of secretin (62 pmol · kg-1 · h- 1) was one-half that of PYY (128 pmol · kg-1 · h-1). Maximal (90{\%}) acid inhibition was produced by 100 pmol · kg-1 · h-1 secretin and 500 pmol · kg-1 PYY. The highest dose of CCK that did not cause vomiting (100 pmol · kg-1 · h-1) inhibited peptone-stimulated acid output by only 60{\%}. After HSV, 500 pmol · kg-1 · h-1 pyy and 200 pmol · kg-1 · h- 1 failed to inhibit acid output by more than 50{\%}. Threshold doses for inhibition by PYY and CCK were 200 and 100 pmol · kg-1 · h-1, respectively. Secretin remained a potent inhibitor after HSV, with an ID50 of 80 pmol · kg-1 · h-1 and a threshold dose of 10 pmol · kg-1 · h-1. HSV also failed to affect inhibition caused by somatostatin. This study has shown that PYY and secretin are somewhat more potent and efficacious inhibitors of acid secretion than CCK but that all three peptides are far more active than GLP-1, neurotensin, and oxyntomodulin. PYY and CCK inhibit acid secretion in large part through vagal innervation of the gastric fundus, but the inhibitory effects of secretin are independent of fundic vagal innervation.",
keywords = "Cholecystokinin, Gastric acid secretion, Gastric inhibitory peptide, Glucagon-like peptide- 1, Neurotensin, Oxyntomodulin, Peptide YY, Secretin, Somatostatin",
author = "Lloyd, {Kevin C K} and S. Amirmoazzami and F. Friedik and A. Heynio and Solomon, {T. E.} and Walsh, {J. H.}",
year = "1997",
month = "5",
language = "English (US)",
volume = "272",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "5 35-5",

}

TY - JOUR

T1 - Candidate canine enterogastrones

T2 - Acid inhibition before and after vagotomy

AU - Lloyd, Kevin C K

AU - Amirmoazzami, S.

AU - Friedik, F.

AU - Heynio, A.

AU - Solomon, T. E.

AU - Walsh, J. H.

PY - 1997/5

Y1 - 1997/5

N2 - The relative contributions of several gut-derived peptides as enterogastrones known to be released in response to a fatty meal and to inhibit acid secretion have not previously been compared directly. We determined the acid-inhibitory activities of increasing intravenous doses of several peptides before and after highly selective vagotomy (HSV) during intragastric titration of a peptone meal in dogs. Before HSV, threshold inhibitory doses of peptide YY (PYY), cholecystokinin (CCK), and secretin were 5, 7, and 10 pmol · kg-1 · h-1, respectively, whereas neurotensin, glucagon-like peptide-1 (GLP-1), and oxyntomodulin failed to inhibit acid secretion at doses up to 1,000 pmol · kg-1 · h-1. The calculated dose producing 50% acid inhibition (ID50) of secretin (62 pmol · kg-1 · h- 1) was one-half that of PYY (128 pmol · kg-1 · h-1). Maximal (90%) acid inhibition was produced by 100 pmol · kg-1 · h-1 secretin and 500 pmol · kg-1 PYY. The highest dose of CCK that did not cause vomiting (100 pmol · kg-1 · h-1) inhibited peptone-stimulated acid output by only 60%. After HSV, 500 pmol · kg-1 · h-1 pyy and 200 pmol · kg-1 · h- 1 failed to inhibit acid output by more than 50%. Threshold doses for inhibition by PYY and CCK were 200 and 100 pmol · kg-1 · h-1, respectively. Secretin remained a potent inhibitor after HSV, with an ID50 of 80 pmol · kg-1 · h-1 and a threshold dose of 10 pmol · kg-1 · h-1. HSV also failed to affect inhibition caused by somatostatin. This study has shown that PYY and secretin are somewhat more potent and efficacious inhibitors of acid secretion than CCK but that all three peptides are far more active than GLP-1, neurotensin, and oxyntomodulin. PYY and CCK inhibit acid secretion in large part through vagal innervation of the gastric fundus, but the inhibitory effects of secretin are independent of fundic vagal innervation.

AB - The relative contributions of several gut-derived peptides as enterogastrones known to be released in response to a fatty meal and to inhibit acid secretion have not previously been compared directly. We determined the acid-inhibitory activities of increasing intravenous doses of several peptides before and after highly selective vagotomy (HSV) during intragastric titration of a peptone meal in dogs. Before HSV, threshold inhibitory doses of peptide YY (PYY), cholecystokinin (CCK), and secretin were 5, 7, and 10 pmol · kg-1 · h-1, respectively, whereas neurotensin, glucagon-like peptide-1 (GLP-1), and oxyntomodulin failed to inhibit acid secretion at doses up to 1,000 pmol · kg-1 · h-1. The calculated dose producing 50% acid inhibition (ID50) of secretin (62 pmol · kg-1 · h- 1) was one-half that of PYY (128 pmol · kg-1 · h-1). Maximal (90%) acid inhibition was produced by 100 pmol · kg-1 · h-1 secretin and 500 pmol · kg-1 PYY. The highest dose of CCK that did not cause vomiting (100 pmol · kg-1 · h-1) inhibited peptone-stimulated acid output by only 60%. After HSV, 500 pmol · kg-1 · h-1 pyy and 200 pmol · kg-1 · h- 1 failed to inhibit acid output by more than 50%. Threshold doses for inhibition by PYY and CCK were 200 and 100 pmol · kg-1 · h-1, respectively. Secretin remained a potent inhibitor after HSV, with an ID50 of 80 pmol · kg-1 · h-1 and a threshold dose of 10 pmol · kg-1 · h-1. HSV also failed to affect inhibition caused by somatostatin. This study has shown that PYY and secretin are somewhat more potent and efficacious inhibitors of acid secretion than CCK but that all three peptides are far more active than GLP-1, neurotensin, and oxyntomodulin. PYY and CCK inhibit acid secretion in large part through vagal innervation of the gastric fundus, but the inhibitory effects of secretin are independent of fundic vagal innervation.

KW - Cholecystokinin

KW - Gastric acid secretion

KW - Gastric inhibitory peptide

KW - Glucagon-like peptide- 1

KW - Neurotensin

KW - Oxyntomodulin

KW - Peptide YY

KW - Secretin

KW - Somatostatin

UR - http://www.scopus.com/inward/record.url?scp=0030943140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030943140&partnerID=8YFLogxK

M3 - Article

C2 - 9176235

AN - SCOPUS:0030943140

VL - 272

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 5 35-5

ER -